Christopher Bowden

Chief Medical Officer, Agios Pharmaceuticals.

Companies

Bicara Therapeutics Inc.Board member Sep 12, 2024 to now¹
ZIOPHARM OncologyBoard member Oct 15, 2019 to Jun 24, 2022²
Agios PharmaceuticalsChief Medical Officer Jun 3, 2014 to Jun 22, 2021³
Viridian Therapeutics, Inc.\DEBoard member Aug 11, 2017 to May 22, 2020⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ZIOPHARM Oncology TCRT44,167 shares⁵$96.3K at $2.18Jun 22, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 22, 2022Granted 40,000 shares of ZIOPHARM Oncology⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBicara Therapeutics Inc., Board member
2
SEC EDGARZIOPHARM Oncology, Board member
3
SEC EDGARAgios Pharmaceuticals, Chief Medical Officer
4
SEC EDGARViridian Therapeutics, Inc.\DE, Board member
5
SEC EDGARZIOPHARM Oncology shares after the filing of Jun 22, 2022